Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Freehill

Sports Medicine Stanford, CA Medical Doctor

NPI 1205973898 CMS profile 100102

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$1,600,371

650 records reported · program years 2019–2025

Research payments

$248,642

Paid to them · 18 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$95,518 paid to institutions, not to them · program year 2019

Through program year 2025, Michael Freehill of Stanford, CA is reported in the CMS Open Payments database as having received $1,600,371 across 650 general payments and $248,642 in research payments paid to them. Separately, studies naming them as principal investigator received $95,518 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $476,854 98
2025 Research $124,801 8
2024 General $381,518 99
2024 Research $123,841 10
2023 General $262,815 112
2022 General $263,118 110
2021 General $107,680 108
2020 General $26,277 28
2019 General $82,108 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Freehill
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Michael Freehill were reported at $476,854. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Michael Freehill Sports Medicine median Middle half National median
2019 $82,108 $1,176 $199–$4,249 $163
2020 $26,277 $708 $96–$2,890 $114
2021 $107,680 $1,213 $152–$3,994 $132
2022 $263,118 $1,230 $159–$3,998 $149
2023 $262,815 $584 $146–$2,836 $160
2024 $381,518 $628 $163–$3,168 $164
2025 $476,854 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $1,356,234 312 payments
  2. Stryker Corporation $169,303 206 payments
  3. Linvatec Corporation $36,620 44 payments
  4. Biorez, Inc. $9,400 2 payments
  5. OSSIO Inc. $9,009 14 payments
  6. Encore Medical, LP $8,750 1 payment
  7. Evolution Surgical, Inc $5,886 13 payments
  8. Xiros Inc $1,558 16 payments
  9. Wright Medical Technology, Inc. $1,238 18 payments
  10. Integra LifeSciences Corporation $866 10 payments
  11. Other $1,507 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,084,183 41 payments
  2. Consulting Fee $292,194 114 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $119,091 35 payments
  4. Travel and Lodging $68,813 153 payments
  5. Food and Beverage $21,600 301 payments
  6. Grant $8,750 1 payment
  7. Education $5,741 5 payments
Products named General payments · program years 2019–2025
  1. AETOS Shoulder System $267,076 75 payments
  2. HEALICOIL Extremities & Limb Restoration $225,702 8 payments
  3. BICEPTOR $201,528 10 payments
  4. HEALICOIL Sports Med Shoulder $147,190 10 payments
  5. HEALICOIL Sports Med Shoulder $137,163 10 payments
  6. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $121,361 154 payments
  7. Coblation $105,309 6 payments
  8. HEALICOIL Sports Med Hip $101,111 3 payments
  9. AEQUALIS PERFORM $52,438 18 payments
  10. Bioinductive Implant with Arthroscopic Delivery System - Medium $48,341 28 payments
  11. Other $493,566 488 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Linvatec Corporation $248,642 18 payments

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$160,077

Medicare's payments for the services billed

Medicare patients

330

Average age 74

Services billed

660

168 women, 162 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Ischemic heart disease 27%
Diabetes 25%
Osteoporosis 24%
Depression 23%
Cancer 21%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

668 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record